Results 131 to 140 of about 16,602 (194)

Real-world efficacy and safety of transarterial chemoembolization plus sintilimab and bevacizumab biosimilar for intermediate-advanced hepatocellular carcinoma: a propensity score matching study. [PDF]

Front Immunol
Deng LW, Liu JF, Yu HY, Peng B, Liu B, Feng SF, Liu DX, Sun YY, Chen Y, Chen JJ, Zhang C, Wang HQ, Xu GH, Liu L, Wei G, Ren Y, Cao L, Zhao Y, Yang XG.   +18 more
europepmc   +1 more source

Transarterial chemoembolization with radioactive seed implantation for multitumor hepatocellular carcinoma. [PDF]

Wideochir Inne Tech Maloinwazyjne
Gao FL, Su Z, Chen DK, Huang XZ, Ma GL.
europepmc   +1 more source

Balloon-Occluded Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma. [PDF]

Indian J Radiol Imaging
Mukund A, Jain K, Sharma LK, Tyagi V, Patidar Y, Shasthry SM, Choudhary AK, Sarin SK.   +7 more
europepmc   +1 more source

Microwave ablation and transcatheter arterial chemoembolization for hepatic epithelioid hemangioendothelioma two case reports with literature review. [PDF]

Discov Oncol
Sun J, Xu C, Liang Q, Zhou K, Pan J.
europepmc   +1 more source

A Case of Microwave Ablation Activating Immune Response in Pulmonary Metastases from Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Wan J, Jin C, Li C, Zhang W, Zhou Y, Yu C, Fan Z, Qu X.   +7 more
europepmc   +1 more source

TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis. [PDF]

Eur Radiol Exp
Ding R, Xu XY, Liu RB, Tie J, Duan XH, Xiong B, Yuan DG, Fan WJ, Wang L, Wu ZQ, Zheng J, Zhao H, Hou CL, Song JL, Zhao BS, Zhu XL, Su YJ, Wang S, Yin GW, Chen L, Zhu HD, Teng GJ, Zhong BY, CHANCE2410 Investigators.   +23 more
europepmc   +1 more source

The Clinical Impact of Cardiovascular Thrombosis on Overall Survival in Patients With Hepatocellular Carcinoma After Transarterial Chemoembolization. [PDF]

Cancer Med
Fujita K, Takuma K, Nakahara M, Suto H, Morishita A, Himoto T, Okano K, Kobara H.   +7 more
europepmc   +1 more source

Delayed percentage attenuation ratio (DPAR) on multiphase CT as a quantitative predictor of early response in hepatocellular carcinoma. [PDF]

Narra J
Supriatna Y, Bachtiar R, Makkaraeng MY, Budiman A.   +3 more
europepmc   +1 more source

Transarterial Infusion of Pembrolizumab Plus TACE for Liver Metastases of Melanoma. [PDF]

Cancer Rep (Hoboken)
Akhlaghpoor S, Rouientan H.
europepmc   +1 more source